Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Oct 22, 2010 (rev. 1)


Philip Bourne, a computational biologist and professor at the University of California, San Diego, has won Microsoft’s Jim Gray eScience Award for his contributions to data-intensive computing.

Bourne is a professor with the Skaggs School of Pharmacy and Pharmaceutical Sciences at UC San Diego, a scientist at the San Diego Supercomputer Center, and the associate director of the RCSB Protein Data Bank.

He is a former president of the International Society for Computational Biology and founding editor-in-chief of PLoS Computational Biology.

Bourne also co-founded SciVee, a web-based resource dedicated to the dissemination of scientific research and science-specific research networking that was launched in 2007 as a collaboration between the National Science Foundation and SDSC.

Bourne's research focus is on relevant biological and educational outcomes derived from computational science and scholarly communication, employing algorithms, text mining, machine learning, meta-languages, biological databases, and visualization to advance discovery in drug effects, evolution, cell signaling, apoptosis, and systems biology.

Geospiza has appointed Bruce Montgomery to its board of directors.

Montgomery recently served as senior vice president of respiratory therapeutics at Gilead Sciences and was a member of the Gilead executive committee. Previously, he founded and served as CEO of Corus Pharmaceuticals. He has also worked as executive vice president of research & development for PathoGenesis, led new product development at Genentech, and taught medicine at the University of California, San Francisco.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.